AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
115 hedge funds and large institutions have $211M invested in Accelerate Diagnostics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
32% less capital invested
Capital invested by funds: $311M → $211M (-$100M)
91% less call options, than puts
Call options by funds: $185K | Put options by funds: $2.15M
Holders
115
Holding in Top 10
3
Calls
$185K
Puts
$2.15M
Top Buyers
| 1 | +$1.96M | |
| 2 | +$1.32M | |
| 3 | +$1.05M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$861K |
| 5 |
Renaissance Technologies
New York
|
+$824K |
Top Sellers
| 1 | -$7.3M | |
| 2 | -$4.56M | |
| 3 | -$2.72M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$2.16M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$1.87M |